Every material Form 8-K IQVIA filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IQVIA reported third-quarter 2026 revenue of $4,428 million, up 8.0%, and Adjusted Diluted EPS of $3.34, up 11.3% year-over-year. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS, which is the key development for shareholders. The filing also discloses a backlog adjustment of approximately $2.1 billion tied to a review of inactive trials, which the company says does not affect 2026 guidance.
Q3 revenue $4,428 million, up 8.0% reported and 8.6% at constant currency; GAAP diluted EPS $2.10 versus $1.93 a year earlier
Full-year 2026 revenue guidance raised to $17,350 million to $17,500 million; Adjusted EBITDA to $4,025 million to $4,055 million
Full-year 2026 Adjusted Diluted EPS guidance raised to $12.90 to $13.00
Backlog adjusted by approximately $2.1 billion after review of inactive trials; R&DS contracted backlog stood at $32.6 billion as of September 30, 2026
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings, completed a $2 billion offering of 6.375% senior notes maturing March 15, 2034. Proceeds will redeem the issuer's 5.000% notes due 2026, repay part of its revolving credit facility and cover offering fees. The deal refinances existing debt and adds new long-term borrowing, which shareholders may weigh against the company's debt load.
Gross proceeds of $2,000,000,000 from 6.375% senior unsecured notes due March 15, 2034
Proceeds to redeem in full the Senior 5.000% Notes due 2026 and repay part of the revolving credit facility
Interest payable semi-annually on March 15 and September 15, starting March 15, 2027
Issuer may redeem before September 15, 2029 subject to a make-whole premium
IQVIA reported second-quarter 2026 revenue of $4,368 million, up 8.7% year-over-year, and adjusted diluted earnings per share of $3.15, up 12.1%. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS, though GAAP net income and GAAP diluted EPS were slightly lower than a year earlier.
Revenue was $4,368 million, up 8.7%; R&D Solutions net new bookings were $3.15 billion, up 19%, with a 1.22x book-to-bill ratio.
GAAP diluted EPS was $1.53 versus $1.54 a year earlier; GAAP net income attributable to IQVIA was $256 million versus $266 million.
Full-year 2026 revenue guidance was raised to $17,275 million–$17,475 million; Adjusted EBITDA to $4,000 million–$4,050 million; Adjusted Diluted EPS to $12.80–$13.00.
The company repurchased $398 million of common stock in the second quarter and had $2,819 million of authorization remaining as of June 30, 2026.
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings, issued €950 million in senior notes maturing June 15, 2033, with proceeds used to refinance existing debt and pay offering fees. The notes add new unsecured debt to the company's obligations, though the filing does not describe the effect on total leverage.
Issued €950,000,000 in gross proceeds of 4.625% senior notes due June 15, 2033, on June 11, 2026
Interest payable semi-annually on June 15 and December 15, beginning December 15, 2026
Proceeds to refinance certain existing indebtedness of the Issuer and pay offering fees and expenses
Optional redemption before June 15, 2029 subject to a make-whole premium; premium steps down from 2.313% to 0.000% thereafter
IQVIA reported first-quarter 2026 revenue of $4,151 million, up 8.4% from a year earlier, and GAAP diluted EPS of $1.61 versus $1.40. The company raised its full-year 2026 adjusted diluted EPS guidance to $12.65-$12.95 while reaffirming its revenue and Adjusted EBITDA guidance, and it repurchased $552 million of its stock during the quarter.
Q1 2026 revenue $4,151 million, up 8.4% reported and 6.0% at constant currency; GAAP net income $274 million versus $249 million a year earlier
Adjusted diluted EPS $2.90, up 7.4% year-over-year; GAAP diluted EPS $1.61 versus $1.40
Full-year 2026 adjusted diluted EPS guidance raised to $12.65-$12.95; revenue guidance of $17,150-$17,350 million and Adjusted EBITDA guidance of $3,975-$4,025 million reaffirmed
Free cash flow $491 million, up 15%; $552 million of common stock repurchased in the quarter, with $1,217 million of authorization remaining as of March 31, 2026
At its April 23, 2026 annual meeting, IQVIA stockholders approved the 2026 Incentive and Stock Award Plan, which replaces the 2017 Plan and takes effect immediately. Stockholders also elected nine directors and voted on other proposals, and the separate Chairman and CEO roles proposal was not approved. The equity plan sets the terms under which future stock-based awards can be granted to employees.
Plan approval: 96,987,612 votes for and 51,006,455 against
Plan replaces the 2017 Incentive and Stock Award Plan and assumes any shares remaining under it
Nine directors elected to one-year terms by majority vote, including Ari Bousbib and Colleen A. Goggins
Separate Chairman and CEO roles proposal: 36,717,802 for and 111,154,252 against
IQVIA reported fourth-quarter 2025 revenue of $4,364 million, up 10.3% from a year earlier, with GAAP diluted EPS of $2.99 and adjusted diluted EPS of $3.42. The company also issued full-year 2026 guidance of $17,150 million to $17,350 million in revenue and $12.55 to $12.85 in adjusted diluted EPS, and said it will recast its segments beginning with the first-quarter 2026 Form 10-Q. For shareholders, the quarter showed revenue and EPS growth, while full-year GAAP net income was slightly lower.
Q4 2025 revenue $4,364 million, up 10.3%; GAAP diluted EPS $2.99, up 23.6%; adjusted diluted EPS $3.42, up 9.6%
Full-year 2025 revenue $16,310 million, up 5.9%; GAAP net income $1,360 million, down 0.9%
2026 guidance: revenue $17,150 million to $17,350 million; adjusted EBITDA $3,975 million to $4,025 million
Share repurchases of $1,244 million in 2025; $1,769 million authorization remaining as of December 31, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IQVIA filing is on SEC EDGAR ↗. 8-K briefs of other companies →